Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma

Journal of Investigative Dermatology

Volumn 100, Issue 2 SUPPL., 1993, Pages

  Jimbow, Kowichi ^a   Iwashina, Takashi ^a   Alena, Frank ^a   Yamada, Koji ^a   Pankovich, Jim ^a   Umemura, Tadahiro ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 S CYSTEAMINYLPHENOL; 4 S CYSTEINYLCATECHOL; 4 S CYSTEINYLPHENOL; PHENOL DERIVATIVE; SULFIDE; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLOGY; CYTOTOXICITY; HUMAN; MELANOMA; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

BENZOQUINONES; CATECHOLS; CYSTEINYLDOPA; DIHYDROXYPHENYLALANINE; DOPAMINE; HUMAN; INDOLES; MELANINS; MELANOMA; MODELS, CHEMICAL; PHENOL; PHENOLS; PIGMENTS; SUPPORT, NON-U.S. GOV'T; TYROSINE;

EID: 0027414380     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.1993.82     Document Type: Article

References (49)

1. K. Jimbow G.J. Lauzon Malignant melanoma: a life threatening skin cancer affecting young people—its diagnosis and management Ann R Coll Phys Surg 23 1990 105 110
2. K. Jimbow Kukita A: Unique location of melanoma, types of chemotherapy and immunotherapy and survival of melanoma patients in Japan Clin Oncol 3 1984 477 492
3. R. Kono K. Jimbow H. Takahashi K. Maeda Ultrasonic measurement of melanosomes for characterization of their physiochemical structure in B16 and Harding Passey melanomas Cancer Res 44 1984 4337 4341
4. K. Jimbow G. Szabo T.B. Fitzpatrick Ultrastructural investigation of autophagocytosis of melanosomes and programmed death of melanocytes in white leghorm feathers: a study of morphogenetic events leading to hypomelanosis Dev Biol 36 1974 8 23
5. K. Jimbow T.G. Salopek W.T. Dixon G.B. Searles K. Yamada The epidermal melanin unit in the pathophysiology of malignant melanoma Am J Dermatopath 13 1991 179 188
6. W. Dixon J. Pankovich F. Alena K. Jimbow A role for cysteine and other sulfhydryl compounds in controlling pigmentation and proliferation of transformed melanocytes (abstr) J Invest Dermatol 94 1990 519A
7. J.M. Pawlek G. Wong M. Sansone J. Marowitz Molecular control in mammalian pigmentation Yale J Biol Med 46 1973 430 443
8. M. Wick B. Frei III Selective incorporation ofL-3, 4-dihydroxypheny-lalanine by S-91 cloudman melanoma in vitro Cancer Res 37 1977 2123 2125
9. K. Jimbow Y. Ito T. Ueda S. Miura Melanocytotoxicity and chemical depigmentation by phenolic and catecholic compounds K. Jimbow Structure and Function of Melanin Vol 3 1986 Fuji Printing Sapporo 31 43
10. M. Wick Dopamine: A novel antitumor agent active against B16 melanoma in vivo J Invest Dermatol 71 1978 163 164
11. M. Wick Therapeutic effect of dopamine infusion on human malignant melanoma Cancer Treat Rep 66 1982 1657 1659
12. J.M. Pawelek M. Murray Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells by phosphorylated isomers of L-dopa Cancer Res 46 1986 493 497
13. J.M. Pawelek A.B. Lerner 5, 6-dihydroxyindole is a melanin precursor showing potent cytotoxicity Nature 276 1978 627 628
14. K. Fujita S. Ito S. Inoue Y. Yamamoto J. Takeuchi M. Shamoto T. Na-gatsu Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo Cancer Res 40 1980 2543 2546
15. K. Jimbow H. Obata M.A. Pathak T.B. Fitzpatrick Mechanism of depigmentation by hydroquinone J Invest Dermatol 62 1974 436 449
16. H. Sugano I. Sugano K. Jimbow T.B. Fitzpatrick Tyrosinase-mediated inhibition of in vitro leucine incorporation into mouse melanoma by 4-isopropylcatechol Cancer Res 35 1975 3126 3130
17. F.S. Vogel L.A.K. Kemper P.W. Jeffs M.W. Cass Graham DG: τ-L-glutaminyl-4-hydroxybenzene, an inducer of cryptobiosis in agaricus bisporus and a source of specific metabolic inhibitors for melanogenic cells Cancer Res 37 1977 1133 1136
18. F.S. Vogel L.A.K. Kemper K. Boekelheide D.G. Graham P.W. Jeffs Intracellular activation of γ- L-glutaminyl-4-hydroxybenzene by tyrosinase, a mechanism for selective cytotoxicity against melanocar-cinoma Cancer Res 39 1979 1490 1493
19. K. Boekelheide D.G. Graham P.D. Mize E.H. Koo Melanocytotoxicity and the mechanism of activation of γ -L-glutaminyl-4-hydroxybenzene J Invest Dermatol 75 1980 322 327
20. B.H. Kahn R.H. Shoemaker S.U. Hildebrand-Zanki J.S. Driscoll Structure-activity relationships defining the cytotoxicity of catechol analogues against human malignant melanoma Cancer Res 48 1988 5178 5182
21. P.A. Riley P.A. Riley Hydroxyanisole; recent advances in antimelanoma therapy 1984 IRL Press Ltd London
22. K. Schwabe I. Fichtner B. Tschiersch Non-selective action of 4-hydroxyanisole on melanoma cells in vivo Pigment Cell Res 3 1990 8 10
23. S. Miura T. Ueda K. Jimbow S. Ito K. Fujita Synthesis of cysteinylphenol, cysteaminylphenol and related compounds and in vivo evaluation of antimelanoma effect Arch Derm Res 279 1987 219 225
24. Y. Ito K. Jimbow Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse—rational basis for its application to melanoma chemotherapy Cancer Res 47 1987 3278 3286
25. 14C] phenol, an experimental antimelanoma agent Appl Radiat Isot 40 1989 539 540
26. 14C] phenol NUC Compact 20 1989 158 159
27. K. Jimbow S. Ito K. Ishikawa T. Kasuga Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma Pigment Cell Res 2 1989 34 39
28. K. Yamada J.M. Pankovich T. Iwashina K. Jimbow Selective in vivo accumulation of phenolic thioether amines into melanoma and identification of a binding glycoprotein (58 kDa) in vitro (abstr) J Invest Dermato 196 1991 549A
29. I.J. Jackson D. Chambers E.M. Rinchik D.C. Bennett Characterization of TRP-1 mRNA levels in dominant and recessive mutations at the mouse brown locus Genetics 126 1990 451 459
30. J. Der K. Jimbow W. Dixon A melanosomal antigen “HMSA-5” as marker of melanocyte differentiation (abstr) Pigment Cell Res 2 1989 456
31. L. Tanenbaum D.L. Tuffanelli Antimalarial agents Arch Dermatol 116 1980 587 591
32. M. Goodall H. Alton Metabolism of 3, 4-dihydroxyphenylalanine (L-DOPA) in human subjects Biochem Pharmacol 21 1972 2401 2408
33. T. Miura K. Jimbow S. Ito The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its N-acetyl derivative Int J Cancer 46 1990 931 934
34. J.M. Pankovich K. Jimbow Tyrosine transport in a human melanotic melanoma cell line as the basis for rational melanoma chemotherapy Biochem J 280 1991 721 725
35. P.G. Parsons F. Favier M. McEwan T. Takahashi K. Jimbow S. Ito Action of cysteaminylphenol in human melanoma cells Melanoma Res 1 1992 97 104
36. S. Ito T. Kato K. Ishikawa T. Kasuga K. Jimbow Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes Biochem Pharmacol 36 1987 2007 2011
37. S.R. Padgette H.H. Herman J.H. Han S.H. Pollock S.W. May Antihypertensive activities of phenol aminoethyl sulfides.a class of synthetic substrates for dopamine β- hydroxylase J Med Chem 27 1984 1354 1357
38. M. Kawase K. Sarnejima M. Okada Mode of action of 3-substituted propylamine cytotoxicity in culture cells Biochem Pharmacol 31 1982 2983 2988
39. J.M. Pankovich K. Jimbow S. Ito 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase Pigment Cell Res 3 1990 146 149
40. S. Inoue S. Ito K. Wakamatsu K. Jimbow K. Fujita Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues Biochem Pharm 39 1990 1077 1083
41. K. Jimbow N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of melasma patients Arch Dermatol 127 1991 1528 1534
42. F. Alena K. Jimbow S. Ito Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo Cancer Res 50 1990 3743 3747
43. J.P. Henry D. Scherman Radioligands of the vesicular monoamine and their use as transporter markers of monoamine storage vesicles Biochem Pharmacol 38 1989 2395 2404
44. A.J. Lin J.A. Kelley T.R. Breiman J.S. Driscoll Agents with potential specificity against melanotic melanoma J Med Chem 25 1982 501 50S
45. J.M. Pawelek After dopachrome? Pigment Cell Res 4 1991 53 62
46. K. Jimbow T.B. Fitzpatrick M.M. Wick Biochemistry and physiology of melanin pigmentation L.A. Goldsmith Physiology, Biochemistry, and Molecular Biology of the Skin Vol. II 1991 Oxford University Press NY 873 909
47. E.P.W. Kable D. Favier P.G. Parsons Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S, R)-sulfoximine Cancer Res 49 1989 2327 2331
48. K. Yamada K. Jimbow R. Engelhardt S. Ito Selective cytotoxicity of a phenolic melanin precursor, 4-S-cysteaminylphenol on in vitro melanoma cells Biochem Pharm 38 1989 2217 2221
49. D. Graham S. Tiffany W. Bell W. Gutknecht Autooxidation versus covalent binding of quinones as the mechanism of toxicity dopamine. 6-hydroxydopamine. and related compounds toward C13000 neuroblastoma cells in vitro Mol Pharmacol 14 1978 644 653